Oct 18 2024
A new study from Georgia State University, published in the journal Drug and Alcohol Dependence, shows that there continues to be issues with misrepresentation of MDMA in unregulated markets across the United States, although there has been improvements in recent years. The research analyzed 4,719 alleged MDMA samples submitted to the DrugsData drug-checking service, aiming …
Oct 18 2024
A study set to be published in the journal Archives of Oral Biology in January 2025 explores the potential biological effects of cannabidiol (CBD) on oral squamous cell carcinoma cells. Conducted by researchers from the University of Perugia in Italy, the study examines CBD as a possible adjuvant therapy in cancer treatment. The study was …
Oct 18 2024
A recent study published in the Canadian Journal of Microbiology demonstrates that the cannabis compound cannabidiol (CBD) may effectively inhibit the growth of Candida albicans, a yeast commonly associated with infections such as oral candidiasis. Researchers treated C. albicans with varying concentrations of CBD, ranging from 0 to 20 µg/mL, and observed a significant reduction …
Oct 17 2024
An early economic analysis published in the journal Expert Review of Pharmacoeconomics & Outcomes Research suggests that medical marijuana could provide notable cost savings when treating chronic pain. The study assessed the cost-effectiveness of cannabis-based medicinal products (CBMPs) compared to other treatment options, such as analgesics, physiotherapy, and cognitive behavioral therapy, over a one-year period …
Oct 15 2024
A recent literature review published in the journal Cells by explores the multifaceted therapeutic effects of cannabidiol (CBD) on the gastrointestinal (GI) system. This non-psychotropic compound, found in Cannabis sativa, has demonstrated promising modulatory effects across various bodily systems, including the central nervous and immune systems. The review, conducted by researchers from the University of …
Oct 14 2024
Researchers from Ahvaz Jundishapur University of Medical Sciences in Iran have discovered that cannabidiol (CBD) can significantly reduce kidney damage caused by arsenic exposure in mice. Published in the peer-reviewed journal Research in Pharmaceutical Sciences, the study explored how CBD influences specific pathways involved in oxidative stress, inflammation, and cell death, particularly the NOX4 and …
Oct 14 2024
A large-scale study involving over 100,000 participants has found that maternal marijuana use during early pregnancy is not associated with an increased risk of offspring developing attention deficit hyperactivity disorder (ADHD) or disruptive behavior disorders (DBD). The study, titled Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort …
Oct 12 2024
2024 has proven to be a landmark year for the research of marijuana and its compounds such as THC and CBD. As marijuana rescheduling to Schedule III looms, the path for future research could soon become even smoother. However, even without this change, significant strides have already been made. Below are the top marijuana, THC, …
Oct 10 2024
Researchers from Jiamusi University, Tianjin First Central Hospital, and Nankai University in China have developed a novel CBD-loaded hydrogel system that may offer a new therapeutic approach for chronic inflammatory bowel disease (IBD), according to a new study. Published in the Journal of Applied Biomaterials & Functional Materials, the study addresses the growing incidence of …
Oct 10 2024
A study conducted by researchers from Colorado State University, published in Frontiers in Veterinary Science, evaluated the effects of cannabidiol (CBD) on dogs with mobility impairments. The double-blind, crossover, placebo-controlled study involved 42 dogs, with 38 completing the trial. For the study, dogs were randomly assigned to receive either CBD oil or a placebo over …
